ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 783

$892K Total Retail Price of All Prescriptions

Rank: 69 out of 783

607 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 11,804 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 826 684 1 3
LEVOTHYROXINE SODIUM 748 636 2 1
AMLODIPINE BESYLATE 493 462 3 5
FUROSEMIDE 471 421 4 7
LISINOPRIL 417 348 5 4
METFORMIN HCL 365 274 6 8
LOSARTAN POTASSIUM 264 241 7 18
GLIMEPIRIDE 255 217 8 34
OMEPRAZOLE 249 188 9 6
METOPROLOL TARTRATE 236 221 10 9
HYDROCHLOROTHIAZIDE 233 218 11 12
WARFARIN SODIUM 222 212 12 10
FENOFIBRATE 209 183 13 66
CITALOPRAM HBR 201 182 14 19
TAMSULOSIN HCL 182 170 15 26
SYNTHROID 175 140 16 47
RANITIDINE HCL 172 149 17 44
METOPROLOL SUCCINATE 156 142 18 13
BYSTOLIC 156 123 18 99
ZOLPIDEM TARTRATE 155 101 20 23
CRESTOR 151 138 21 27
ATORVASTATIN CALCIUM 149 130 22 11
HYDROCODONE-ACETAMINOPHEN 148 93 S3 23 2
CLOPIDOGREL 146 128 24 29
TRICOR 141 85 25 134
PLAVIX 133 126 26 51
PRAVASTATIN SODIUM 132 101 27 14
CARVEDILOL 121 119 28 21
LOSARTAN-HYDROCHLOROTHIAZIDE 118 95 29 53
KLOR-CON M20 117 86 30 48
LANTUS 110 73 31 38
FLUTICASONE PROPIONATE 106 75 32 46
ATENOLOL 106 95 32 17
AZOR 105 102 34 287
NEXIUM 105 80 34 28
PANTOPRAZOLE SODIUM 102 91 36 30
ZETIA 101 63 37 80
JANUVIA 100 87 38 73
AZITHROMYCIN 98 80 39 41
GABAPENTIN 92 77 40 15
VYTORIN 90 78 41 161
POTASSIUM CHLORIDE 89 70 42 16
LOVAZA 84 22 43 163
LANTUS SOLOSTAR 78 74 44 91
BUPROPION XL 74 60 45 172
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 63 46 33
ALENDRONATE SODIUM 71 71 47 25
DIGOXIN 68 68 48 61
NOVOLOG FLEXPEN 67 67 49 142
EXFORGE 65 50 50 223
CIPROFLOXACIN HCL 61 58 51 62
DIOVAN 61 49 51 49
SERTRALINE HCL 61 49 51 22
SPIRIVA 61 49 51 59
ESCITALOPRAM OXALATE 60 46 55 54
MELOXICAM 59 59 56 37
BENICAR 58 52 57 182
NAMENDA 58 58 57 32
BENAZEPRIL HCL 58 58 57 85
NIFEDIPINE ER 56 44 60 135
ALPRAZOLAM 55 54 61 145
SINGULAIR 54 48 62 90
RAMIPRIL 54 54 62 113
TRAMADOL HCL 54 48 62 20
INSULIN SYRINGE 52 47 65 82
FLUOXETINE HCL 52 33 65 45
ISOSORBIDE MONONITRATE ER 51 51 67 40
TRIAMTERENE-HCTZ 50 47 68 42
VESICARE 50 49 68 188
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.